Journal of Gastrointestinal Infections

Register      Login

VOLUME 6 , ISSUE 1 ( 2016 ) > List of Articles

CASE REPORT

Esophageal candidiasis in an immunocompetent host: case report and review of literature

Aminder Singh, Rajoo Singh Chhina, Omesh Goyal, Prerna Goyal, Pavneet Kaur

Keywords : Esophageal candidiasis, fluconazole, immunocompetent

Citation Information : Singh A, Chhina RS, Goyal O, Goyal P, Kaur P. Esophageal candidiasis in an immunocompetent host: case report and review of literature. J Gastrointest Infect 2016; 6 (1):54-56.

DOI: 10.5005/jp-jogi-6-1-54

License: CC BY-SA 4.0

Published Online: 01-12-2016

Copyright Statement:  Copyright © 2016; Jaypee Brothers Medical Publishers (P) Ltd.


Abstract

Infection by Candida species is the most common cause of infectious esophagitis in adults. Esophageal candidiasis (EC) occurs most commonly in immunocompromised hosts, such as those with human immunodeficiency virus infection. However, EC may also occur in immunocompetent individuals with or without apparent predisposing risk factors and symptoms. We report a case of EC incidentally discovered in an immunocompetent middle age male who underwent esophagogastro- duodenoscopy for dyspeptic symptoms. The only potential risk factor was long-term use of alcohol. Treatment with fluconazole led to complete resolution of EC.


PDF Share
  1. Laine L, Bonacini M. Esophageal disease in human immunodeficiency virus infection. Arch Intern Med. 1994;154:1577-82.
  2. Choi JH, Lee CG, Lim YJ, Kang HW, Lim CY, Choi JS. Prevalence and risk factors of esophageal candidiasis in healthy individuals: a single center experience in Korea. Yonsei Med J. 2013;54:160-5.
  3. Baehr PH, McDonald GB. Esophageal infections: risk factors, presentation, diagnosis and treatment. Gastroenterology. 1994;106:509-32.
  4. Ahmed ME, Elfeil MS, Ali IA, Abdelrahim MI, Tamim AA, Khalid MK. Oesophageal candidiasis in an immunocompetent adult, an adverse effect of antibiotic therapy following cardiac surgery, case report and review of literature. East Afr Med J. 2012;89:246-9.
  5. Vazquez JA. Mucosal candidiasis. Infect Dis Clin N Am. 2002;16:793-820.
  6. Cuenca-Estrella M1, Verweij PE, Arendrup MC, Arikan-Akdagli S, Bille J, Donnelly JP et al. ESCMID guideline for the diagnosis and management of Candida diseases 2012: diagnostic procedures. Clin Microbiol Infect. 2012;18(S7):9-18.
  7. Naito Y, Yoshikawa T, Oyamada H, Tainaka K, Morita Y, Kogawa T et al. Esophageal candidiasis. Gastroenterol Jpn. 1988;23:363- 70.
  8. Kakati B, Kotwal A, Biswas D, Sahu S. Fluconazole Resistant Candida Oesophagitis in Immunocompetent Patients: Is Empirical Therapy Justifiable? J Clin Diagn Res. 2015;9:16-8.
  9. Hoshika K, Iida M, Mine H. Esophageal Candida infection and adherence mechanisms in the non immunocompromised rabbit. J Gastroenterol. 1996;31:307-13.
  10. Tran HA, Vincent JM, Slavin MA, Grigg A. Esophageal perforation secondary to angioinvasive Candida glabrata following hemopoietic stem cell transplantation. Clin Microbiol Infect. 2003;9: 1215-8.
PDF Share

© Jaypee Brothers Medical Publishers (P) LTD.